No Barrier
Category: AI in Healthcare
AI-powered real-time medical interpretation platform breaking language barriers in healthcare encounters No Barrier was founded in 2023. The company is led by Eyal Heldenberg. Based in San Francisco, CA, USA. Team size: 10-50. Total funding raised: $2.7 million. Latest round: Seed, $2.7 million, November 2025, led by A-Squared Ventures. Key investors include A-Squared Ventures, Esplanade Ventures, Rock Health Capital, Fusion.
- Founded
- 2023
- Headquarters
- San Francisco, CA, USA
- Team size
- 10-50
- Total funding
- $2.7 million
Value proposition
HIPAA-compliant, clinically-accurate instant interpretation across 40+ languages to improve diagnostic accuracy and patient outcomes
Products and solutions
Real-time speech-to-speech interpretation, Phone interpretation, Video interpretation, Text-based medical translation, Specialized terminology support for clinical settings
Unique value
Medical AI trained on clinical terminology and workflows, with HIPAA compliance and healthcare-specific NLP models
Target customer
Healthcare providers, hospitals, clinics, and patients requiring multilingual medical communication
Industries served
Hospital & Clinical Care, Telemedicine Platforms, Emergency Medical Services, Public Health Systems
Technology advantage
Proprietary speech recognition engine optimized for medical contexts, integrated with EHR systems via API
How they differentiate
No Barrier differentiates itself through AI-powered real-time medical interpretation with 40+ language support, HIPAA compliance, and evidence-based accuracy validated in clinical studies. Unlike human interpreters or competitors' solutions, it offers 24/7 availability, instant deployment, and integration with EHR systems.
Main competitors
Verbal, Jaide Health, LanguageLine, AMN Language Services, CyraCom
Key partnerships
NACHC Accelerator 2026, A-Squared Ventures, Rock Health Capital, Esplanade Ventures, Fusion (investor network)
Notable customers
Community Clinic NWA, UC Health, Providence St. Joseph Health
Major milestones
2023: Launched AI medical interpretation platform, 2024: Published first scientific study showing 98% accuracy in clinical terminology, 2024: Achieved HIPAA compliance and SOC 2 certification, 2025: Secured integration with Epic and Cerner EHR systems, 2025: Raised $2.7M Seed round led by A-Squared Ventures and Esplanade Ventures, 2026: Selected for NACHC Accelerator 2026 cohort, 2026: Expanded to 150+ medical sites across 12 states
Growth metrics
150+ medical sites deployed across 12 states as of May 2026
Market positioning
Positioned as an AI-native medical interpretation leader, targeting hospitals, clinics, and telehealth providers needing scalable, cost-effective language solutions. Focuses on acute care settings where rapid interpretation is critical.
Geographic focus
Primarily serving the U.S. healthcare market with expansion into Canadian healthcare systems. Competitors like LanguageLine have broader global reach, but No Barrier emphasizes U.S. healthcare regulatory compliance.
Patents and IP
Pending applications for medical language processing algorithms (no public patents filed yet)
About Eyal Heldenberg
20+ years in voice AI innovation, serial entrepreneur in speech recognition and AI-driven communication platforms
Official website: https://www.nobarrier.ai